MJ

Manish Jain

Active Director Director DIN 08152480
DIN 08152480 First appointment Jun 2018 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2018
Shareholding value •••• Premium profile

About Manish Jain

Data last updated:

Manish Jain is a Director at Lwe Care Pharmaceuticals Private Limited (since 2018). The company operates in Trading. Lwe Care Pharmaceuticals Private Limited reported revenue of ₹93.7 Lakh (FY 2025).

DIN 08152480
Primary Designation Director
Industry Trading
First Appointment 07 Jun 2018
Oldest Company Age 8 yrs
Largest company Lwe Care Pharmaceuticals Private Limited · ₹93.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jun 20182018₹93.7 Lakh (FY 2025)Active

Board colleagues of Manish Jain

NameDINCompanyDesignation
Sangam Jain08152479Lwe Care Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lwe Care Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manish Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manish Jain

Manish Jain currently holds 1 directorship: Lwe Care Pharmaceuticals Private Limited (Director, since 07 Jun 2018, revenue ₹93.7 Lakh (FY 2025)).

Manish Jain was first appointed on 07 Jun 2018 as Director at Lwe Care Pharmaceuticals Private Limited.

The current boards of Manish Jain's companies include Sangam Jain (Lwe Care Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available